Josephine H Cox - JoVE Visualize

Showing results (1-10 of 51) with videos related to

Pageof 6

Sort By:

Methods (San Diego, Calif.)|February 14, 2006

Measurement of cytokine release at the single cell level using the ELISPOT assayJosephine H Cox, Guido Ferrari, Sylvia Janetzki

Methods in Molecular Biology (Clifton, N.J.)|June 7, 2005

Standardization and validation issues of the ELISPOT assaySylvia Janetzki, Josephine H Cox, Neal Oden, et al.

Expert Review of Vaccines|September 23, 2006

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV developmentMichael R Betts, Clive M Gray, Josephine H Cox, et al.

AIDS Research and Human Retroviruses|January 25, 2005

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trialsJosephine H Cox, Guido Ferrari, Spyros A Kalams, et al.

Journal of Virology|April 23, 2002

Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesJeffrey R Currier, Mark deSouza, Penprapa Chanbancherd, et al.

AIDS (London, England)|July 2, 2005

HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptidesAlleluiah Rutebemberwa, Jeffrey R Currier, Linda Jagodzinski, et al.

Journal of Virology|January 11, 2008

Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variantsGabriela Turk, María Magdalena Gherardi, Natalia Laufer, et al.

AIDS Research and Human Retroviruses|March 30, 2005

Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected EthiopiansJeffrey R Currier, Matthew E Harris, Josephine H Cox, et al.

BMC Immunology|April 20, 2006

CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL responseJeffrey R Currier, Unchalee Visawapoka, Sodsai Tovanabutra, et al.

Clinical and Vaccine Immunology : CVI|July 28, 2012

A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteersJakub Kopycinski, Hannah Cheeseman, Ambreen Ashraf, et al.

Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:

Pageof 6

Methods (San Diego, Calif.)|February 14, 2006

Measurement of cytokine release at the single cell level using the ELISPOT assayJosephine H Cox, Guido Ferrari, Sylvia Janetzki

Methods in Molecular Biology (Clifton, N.J.)|June 7, 2005

Standardization and validation issues of the ELISPOT assaySylvia Janetzki, Josephine H Cox, Neal Oden, et al.

Expert Review of Vaccines|September 23, 2006

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV developmentMichael R Betts, Clive M Gray, Josephine H Cox, et al.

AIDS Research and Human Retroviruses|January 25, 2005

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trialsJosephine H Cox, Guido Ferrari, Spyros A Kalams, et al.

Journal of Virology|April 23, 2002

Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesJeffrey R Currier, Mark deSouza, Penprapa Chanbancherd, et al.

AIDS (London, England)|July 2, 2005

HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptidesAlleluiah Rutebemberwa, Jeffrey R Currier, Linda Jagodzinski, et al.

Journal of Virology|January 11, 2008

Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variantsGabriela Turk, María Magdalena Gherardi, Natalia Laufer, et al.

AIDS Research and Human Retroviruses|March 30, 2005

Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected EthiopiansJeffrey R Currier, Matthew E Harris, Josephine H Cox, et al.

BMC Immunology|April 20, 2006

CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL responseJeffrey R Currier, Unchalee Visawapoka, Sodsai Tovanabutra, et al.

Clinical and Vaccine Immunology : CVI|July 28, 2012

A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteersJakub Kopycinski, Hannah Cheeseman, Ambreen Ashraf, et al.

Pageof 6